Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JonesTrading Downgrades Concert Pharma to Hold

JonesTrading Downgrades Concert Pharma to Hold

JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.

byBenzinga Newsdesk

January 20, 2023

1 minute read

JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.

Coinbase CEO Predicts Eye-Popping Number Of Crypto Users Within 10 Years

By Mehab Qureshi

April 18, 2:38 AM

Coinbase (NASDAQ:COIN) CEO Brian Armstrong has made a prediction about the future of cryptocurrencies like Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:

BTC

Cathie Wood’s Ark Invest Makes Major Quantum-Si Purchase — Loads Up On 1.4M Shares Of Semiconductor Firm

By Benzinga Newsbot

July 13, 11:39 PM

Ark Invest, led by Cathie Wood, made some significant trades on Thursday. The most notable was the purchase…

CDXS

Analyst Ratings

Expert Ratings for Eversource Energy

By Benzinga Insights

November 7, 11:00 AM

Eversource Energy (NYSE:ES) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

Bunge Q2: Sales Plunge 16%, Beats On EPS, Boosts FY23 EPS Outlook & More

By Shivani Kumaresan

August 2, 9:03 AM

Bunge Ltd (NYSE: BG) reported a

JonesTrading Downgrades Concert Pharma to Hold

Related Posts

Coinbase CEO Predicts Eye-Popping Number Of Crypto Users Within 10 Years

Cathie Wood’s Ark Invest Makes Major Quantum-Si Purchase — Loads Up On 1.4M Shares Of Semiconductor Firm

Expert Ratings for Eversource Energy

Bunge Q2: Sales Plunge 16%, Beats On EPS, Boosts FY23 EPS Outlook & More